Megan Hatlen

1.1k total citations
12 papers, 459 citations indexed

About

Megan Hatlen is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Megan Hatlen has authored 12 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Hematology and 4 papers in Immunology. Recurrent topics in Megan Hatlen's work include Acute Myeloid Leukemia Research (4 papers), Cancer-related gene regulation (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Megan Hatlen is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Cancer-related gene regulation (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Megan Hatlen collaborates with scholars based in United States, South Korea and Canada. Megan Hatlen's co-authors include Stephen D. Nimer, Lan Wang, Xinyang Zhao, Lan Wang, Ross L. Levine, Fan Liu, Ayalew Tefferi, A DeBlasio, Fabiana Perna and Michael W. Harr and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Cancer Cell.

In The Last Decade

Megan Hatlen

12 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Megan Hatlen United States	7	370	166	115	51	43	12	459
Fiorella Schischlik Austria	9	215 0.6×	70 0.4×	78 0.7×	68 1.3×	37 0.9×	19	314
Keh-Dong Shiang United States	6	214 0.6×	159 1.0×	91 0.8×	64 1.3×	103 2.4×	7	383
Paula de Melo Campos Brazil	11	147 0.4×	168 1.0×	83 0.7×	69 1.4×	28 0.7×	43	353
Samantha L. Savage United States	5	232 0.6×	115 0.7×	46 0.4×	102 2.0×	43 1.0×	12	314
Ema Anastasiadou United States	6	254 0.7×	351 2.1×	121 1.1×	73 1.4×	30 0.7×	7	500
Laura García-Ortí Spain	5	311 0.8×	161 1.0×	73 0.6×	58 1.1×	77 1.8×	6	397
Edward Kavalerchik United States	6	188 0.5×	244 1.5×	142 1.2×	125 2.5×	14 0.3×	17	358
Giacomo Tuana Italy	8	197 0.5×	105 0.6×	84 0.7×	37 0.7×	108 2.5×	12	314
Jason G. Harb United States	12	385 1.0×	245 1.5×	168 1.5×	60 1.2×	191 4.4×	30	570
Luana Bavaro Italy	6	101 0.3×	191 1.2×	137 1.2×	48 0.9×	24 0.6×	7	274

Countries citing papers authored by Megan Hatlen

Since Specialization

Citations

This map shows the geographic impact of Megan Hatlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Hatlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Hatlen more than expected).

Fields of papers citing papers by Megan Hatlen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan Hatlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Hatlen. The network helps show where Megan Hatlen may publish in the future.

Co-authorship network of co-authors of Megan Hatlen

This figure shows the co-authorship network connecting the top 25 collaborators of Megan Hatlen. A scholar is included among the top collaborators of Megan Hatlen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan Hatlen. Megan Hatlen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Grassian, Alexandra, Andrew M. Haidle, James Α. Baker, et al.. (2024). BLU-808, a Potent and Selective Small Molecule Inhibitor of Wild-type c-KIT for Mast Cell Disorders. Journal of Allergy and Clinical Immunology. 153(2). AB62–AB62. 4 indexed citations

Hatlen, Megan, Oleg Schmidt-Kittler, Cori Ann Sherwin, et al.. (2019). Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma. Cancer Discovery. 9(12). 1686–1695. 90 indexed citations

Man, Na, Xiao‐Jian Sun, Yurong Tan, et al.. (2016). Differential role of Id1 in MLL-AF9–driven leukemia based on cell of origin. Blood. 127(19). 2322–2326. 14 indexed citations

Asai, Takashi, Megan Hatlen, Delphine Ndiaye‐Lobry, et al.. (2016). Generation of a novel, multi-stage, progressive, and transplantable model of plasma cell neoplasms. Scientific Reports. 6(1). 22760–22760. 4 indexed citations

Hamard, Pierre-Jacques, Luisa Luciani, Fan Liu, et al.. (2015). Prmt5 Negatively Regulates Erythropoiesis By Multiple Mechanisms, Including Controlling DNA Methyltransferase 3A Protein Levels. Blood. 126(23). 1181–1181. 1 indexed citations

Wang, Lan, Na Man, Xiao‐Jian Sun, et al.. (2015). Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression. Blood. 126(5). 640–650. 25 indexed citations

Hatlen, Megan, Kanika Arora, Vladimir Vacic, et al.. (2015). Integrative genetic analysis of mouse and human AML identifies cooperating disease alleles. The Journal of Experimental Medicine. 213(1). 25–34. 19 indexed citations

Hatlen, Megan, Lan Wang, & Stephen D. Nimer. (2012). AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches. Frontiers of Medicine. 6(3). 248–262. 53 indexed citations

Liu, Fan, Xinyang Zhao, Fabiana Perna, et al.. (2011). JAK2V617F-Mediated Phosphorylation of PRMT5 Downregulates Its Methyltransferase Activity and Promotes Myeloproliferation. Cancer Cell. 19(2). 283–294. 219 indexed citations

10.

Harr, Michael W., Xinyang Zhao, Mary E. Klein, et al.. (2011). JAK2 V617F, PRMT5, and GATA-1 Form a Regulatory Loop That Controls Autophagy Via Effects on ATG3 Gene Expression. Blood. 118(21). 2822–2822. 1 indexed citations

11.

Wang, Lan, Gang Huang, Xinyang Zhao, et al.. (2009). Post-translational modifications of Runx1 regulate its activity in the cell. Blood Cells Molecules and Diseases. 43(1). 30–34. 28 indexed citations

12.

Hatlen, Megan, et al.. (2008). Natural human IgE peptide‐specific CTL inhibit human IgE production and eliminate U266 in HLA‐A2 transgenic rodents. The FASEB Journal. 22(S1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact